NuVasive Total Assets 2006-2019 | NUVA

NuVasive total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
NuVasive Annual Total Assets
(Millions of US $)
2018 $1,708
2017 $1,640
2016 $1,571
2015 $1,303
2014 $1,342
2013 $1,180
2012 $1,164
2011 $1,124
2010 $802
2009 $653
2008 $487
2007 $226
2006 $196
2005 $71
NuVasive Quarterly Total Assets
(Millions of US $)
Q2 2019 $1,805
Q1 2019 $1,751
Q4 2018 $1,708
Q3 2018 $1,675
Q2 2018 $1,672
Q1 2018 $1,671
Q4 2017 $1,640
Q3 2017 $1,629
Q2 2017 $1,606
Q1 2017 $1,570
Q4 2016 $1,571
Q3 2016 $1,636
Q2 2016 $1,606
Q1 2016 $1,569
Q4 2015 $1,303
Q3 2015 $1,272
Q2 2015 $1,286
Q1 2015 $1,296
Q4 2014 $1,342
Q3 2014 $1,269
Q2 2014 $1,254
Q1 2014 $1,225
Q4 2013 $1,180
Q3 2013 $1,140
Q2 2013 $1,108
Q1 2013 $1,101
Q4 2012 $1,164
Q3 2012 $1,185
Q2 2012 $1,167
Q1 2012 $1,149
Q4 2011 $1,124
Q3 2011 $1,115
Q2 2011 $1,273
Q1 2011 $807
Q4 2010 $802
Q3 2010 $711
Q2 2010 $686
Q1 2010 $666
Q4 2009 $653
Q3 2009 $633
Q2 2009 $599
Q1 2009 $525
Q4 2008 $487
Q3 2008 $469
Q2 2008 $453
Q1 2008 $447
Q4 2007 $226
Q3 2007 $216
Q2 2007 $210
Q1 2007 $207
Q4 2006 $196
Q3 2006 $194
Q2 2006 $208
Q1 2006 $210
Q4 2005 $71
Q3 2005 $74
Q2 2005 $83
Q1 2005 $80
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.387B $1.102B
NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.939B 20.91
Abbott Laboratories (ABT) United States $147.101B 27.65
Stryker (SYK) United States $82.696B 28.60
Boston Scientific (BSX) United States $59.981B 29.09
Baxter (BAX) United States $44.653B 27.08
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.674B 18.35
Lonza Group Ag (LZAGY) Switzerland $25.863B 0.00
Coloplast (CLPBY) Denmark $25.834B 41.24
Terumo (TRUMY) Japan $23.226B 26.71
Smith & Nephew SNATS (SNN) United Kingdom $20.906B 0.00
ResMed (RMD) United States $19.182B 36.58
Sunny Optical Technology (SNPTF) China $16.804B 0.00
Bio-Rad Laboratories (BIO) United States $10.124B 54.27
Insulet (PODD) United States $9.197B 544.96
Canopy Growth (CGC) Canada $9.163B 0.00
Perrigo (PRGO) Ireland $7.388B 13.61
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.984B 20.82
Haemonetics (HAE) United States $6.525B 49.24
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.265B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.167B 0.00
Neogen (NEOG) United States $4.002B 66.44
ICU Medical (ICUI) United States $3.307B 21.45
Hutchison China MediTech (HCM) China $2.719B 0.00
Quidel (QDEL) United States $2.651B 26.33
Agios Pharmaceuticals (AGIO) United States $2.117B 0.00
National Vision Holdings (EYE) United States $2.015B 43.49
Cardiovascular Systems (CSII) United States $1.761B 0.00
Aphria (APHA) $1.519B 0.00
VAREX IMAGING (VREX) United States $1.090B 25.12
AtriCure (ATRC) United States $1.008B 0.00
Lantheus Holdings (LNTH) United States $1.003B 26.37
Omeros (OMER) United States $0.896B 0.00
Phibro Animal Health (PAHC) United States $0.881B 14.34
Eagle Pharmaceuticals (EGRX) United States $0.802B 20.45
NanoString Technologies (NSTG) United States $0.801B 0.00
Cerus (CERS) United States $0.745B 0.00
PetIQ (PETQ) United States $0.730B 17.25
LeMaitre Vascular (LMAT) United States $0.709B 42.01
MacroGenics (MGNX) United States $0.636B 0.00
Surmodics (SRDX) United States $0.620B 117.92
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.599B 0.00
OraSure Technologies (OSUR) United States $0.462B 21.40
Meridian Bioscience (VIVO) United States $0.407B 12.71
BioLife Solutions (BLFS) United States $0.396B 130.13
Utah Medical Products (UTMD) United States $0.368B 26.98
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.351B 0.00
Owens & Minor (OMI) United States $0.349B 10.47
Zynex (ZYXI) United States $0.315B 33.45
United Health Products (UEEC) United States $0.270B 0.00
Bovie Medical (APYX) United States $0.247B 0.00
Rockwell Medical (RMTI) United States $0.207B 0.00
Cytosorbents (CTSO) United States $0.178B 0.00
Vapotherm (VAPO) United States $0.174B 0.00
Chimerix (CMRX) United States $0.143B 0.00
Fonar (FONR) United States $0.142B 10.11
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Female Health (VERU) United States $0.122B 0.00
InfuSystems Holdings (INFU) United States $0.105B 0.00
United-Guardian (UG) United States $0.085B 20.07
Nephros (NEPH) United States $0.068B 0.00
MRI Interventions (MRIC) United States $0.066B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.027B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00